• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biostem Technologies New (OP:BSEM)

4.320 -0.714 (-14.18%)
Streaming Delayed Price Updated: 3:53 PM EDT, May 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biostem Technologies New

News headline image
BioStem Technologies Q1 Earnings Call Highlights ↗
May 15, 2026
BioStem Technologies (OTCMKTS:BSEM) said its first quarter of 2026 marked a major shift in its business model following a late-January acquisition that moved the company’s focus from physician offices... 
Via MarketBeat
Topics Earnings
News headline image
Biotech Healthcare: CSDX, NWBO, BSEM, RDGL, NRXBF Emerging Stocks to Watch
February 05, 2026
Via AB Newswire
BioStem Technologies Innovative Wound-Care Treatments Steepen Its Growth Trajectory ($BSEM)
July 16, 2024
Via AB Newswire
BioStem Technologies Inc. In A Race To The Top With Innovative Wound-Care Treatments ($BSEM)
July 15, 2024
Via AB Newswire
Topics Intellectual Property
News headline image
BioStem Technologies Announces Opening of First Clinical Site for Diabetic Foot Ulcer Study
October 24, 2023
Via ACCESSWIRE
News headline image
BioStem Technologies to Highlight Core Advanced Wound Care Portfolio at SAWC Fall 2023 Conference
October 17, 2023
Via ACCESSWIRE
News headline image
BioStem Technologies: CMS Decision a “Win For Patients”
September 29, 2023
Via ACCESSWIRE
News headline image
BioStem Receives IRB Approval for Clinical Study to Evaluate Vendaje(R) in Diabetic Foot Ulcers
September 26, 2023
Via ACCESSWIRE
News headline image
BioStem Technologies Initiates Nationwide Launch of AmnioWrap2(TM) with Venture Medical
September 19, 2023
Via ACCESSWIRE
News headline image
BioStem Technologies Engages PCG Advisory for Strategic Investor Relations
September 18, 2023
Via ACCESSWIRE
News headline image
NovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® Allograft
September 11, 2023
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
How BioStem Plans To Grow Its Perinatal Allografts In 2023 – And Beyond ↗
January 30, 2023
Florida-based BioStem Technologies, Inc. (OTCMKTS: BSEM) is a biotech company focused on developing and manufacturing structural-tissue allografts derived from perinatal tissues and intended for use as... 
Via Benzinga
News headline image
2022 Year in Review: BioStem Technologies Looks Back At A Year of Growth And Expansion ↗
January 13, 2023
BioStem Technologies, Inc. (OTCQB: BSEM) is a Florida-based biotechnology company focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization... 
Via Benzinga
News headline image
BioStem Technologies Announces Partnership with Kill Cliff FC
December 14, 2022
From BioStem Technologies, Inc.
Via GlobeNewswire
News headline image
BioStem Technologies Reports Third Quarter 2022 Operating and Financial Results
November 15, 2022
From BioStem Technologies, Inc.
Via GlobeNewswire
News headline image
BioStem Technologies to Host Third Quarter Financial Results and Corporate Update Conference Call
November 15, 2022
From BioStem Technologies, Inc.
Via GlobeNewswire
News headline image
BioStem Promotes Michael Fortunato, CPA to Chief Financial Officer
October 26, 2022
From BioStem Technologies, Inc.
Via GlobeNewswire
News headline image
BioStem to Present at the Dawson James Securities 2022 Small Cap Growth Conference
October 10, 2022
From BioStem Technologies, Inc.
Via GlobeNewswire
News headline image
BioStem Technologies (OTCMKTS: BSEM) Coverage Initiated at Zacks Investment Research ↗
September 22, 2022
The below report was authored by Brad Sorensen, CFA, Zacks Small Cap Research. You can find the original report here.   
Via Benzinga
News headline image
EXCLUSIVE: BioStem Technologies Reports Q1 Net Revenue Up 211% YoY ↗
May 16, 2022
BioStem Technologies Inc. (OTC: BSEM), a regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics today, reported financial results... 
Via Benzinga
Cannabis Movers & Shakers: Halo Collective, Suite 420 Access, OWP, BioStem, Chicago Atlantic Advisors, Silo Wellness ↗
April 22, 2021
Halo Collective Taps Have a Heart's CEO Ryan Kunkel Halo Collective Inc. (NEO:HALO)(OTCQX: 
Via Benzinga
Topics Cannabis
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap